Brazil Halts and Re-Starts Phase 3 Clinical Trials of Chinese COVID-19 Vaccine

Brazil Halts and Re-Starts Phase 3 Clinical Trials of Chinese COVID-19 Vaccine

Brazil briefly stopped clinical trials of CoronaVac, the Chinese-made experimental vaccine for COVID-19, after a death among trial participants was reported on Nov 9, 2020. The Bhutantan Institute in San Paulo, Brazil had been conducting Phase 3 trials with more than 10,000 volunteers when the study was halted.1 However, within days, Bhutantan officials announced they […]

Brazilian Doctor Dies Participating in AstraZeneca’s COVID-19 Vaccine Clinical Trial

Brazilian Doctor Dies Participating in AstraZeneca’s COVID-19 Vaccine Clinical Trial

Story Highlights A COVID-19 vaccine trial participant, who was a physician working with COVID-19 patients at hospitals in Brazil, has reportedly died from coronavirus infection complications. It has not been confirmed, but sources indicate the victim was given the trial “placebo” (a meningococcal vaccine) and not the experimental AZD1222 vaccine developed by pharmaceutical company AstraZeneca […]

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event

News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]

Fauci Says Rushing COVID-19 Vaccine is Risky

Fauci Says Rushing  COVID-19 Vaccine is Risky

During a remote online testimony before the U.S. Senate’s Health, Education, Labor and Pensions Committee on May 12, 2020, Anthony Fauci, MD warned that moving forward too quickly with the development of a vaccine for COVID-19 may produce a vaccine that could make the disease worse.1 2 Dr. Fauci, who is the director of the […]

Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline

Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline

On Mar. 17, 2020, European Commission (EC) president Ursula von der Leyen said she was hopeful a vaccine for COVID-19 could be available this September. Her view was based on conversations she had had with managers of German biotechnology firm CureVac AG which has developed an experimental messenger RNA (mRNA) vaccine that it plans to […]